ERBB2 and cervical cancer: We implanted non-transfected or transfected human cervical cancer cells (vector, Cdc25A, Cdc25A + sh-NC, Cdc25A + sh-ErbB2) into nude mice, and 7 days later, saline or sorafenib was injected intraperitoneally every other day for 30 days.